Differences in the quality of care for women with an abnormal mammogram or breast complaint
Journal of General Internal MedicinePublished 1 May 2000Open access
Jennifer S. Haas, E. Francis Cook, Ann Louise Puopolo, Helen Burstin, Troyen A. Brennan
Citations57
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
It is found that a substantial proportion of women with a breast problem managed by generalists did not receive care consistent with a clinical guideline, particularly younger women with an abnormal mammogram and a normal or benign-appearing mammogram.
Abstract
We found that a substantial proportion of women with a breast problem managed by generalists did not receive care consistent with a clinical guideline, particularly younger women with a clinical breast complaint and a normal or benign-appearing mammogram.
Keywords
Medicine
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
New England Journal of MedicineTen-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations
1,055 Citations1998Joann G. Elmore, Mary B. Barton +4 more
Over 10 years, one third of women screened had an abnormal test result that required additional evaluation, even though no breast cancer was present, and Physicians should educate women about the risk of a false positive result from a screening test for breast cancer.
New England Journal of MedicineRelation between Malpractice Claims and Adverse Events Due to Negligence
727 Citations1991A. Russell Localio, Ann G. Lawthers +7 more
JAMARacial Differences in Survival From Breast Cancer
537 Citations1994J. William Eley
Almost 75% of the racial difference in survival was explained by the prognostic factors studied, and Sociodemographic variables appeared to act largely through racial differences in stage at diagnosis, which may be amenable to change through improved access to and use of screening for black women.
JAMAEffect of Age, Breast Density, and Family History on the Sensitivity of First Screening Mammography
491 Citations1996Karla Kerlikowske
The sensitivity of modern mammography is highest among women aged 50 years and older who have primarily fatty breast density and particularly low when the time between screenings is about 2 years or when women have a family history of breast cancer.
American Journal of Public HealthDeterminants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type.
250 Citations1991Jeanne S. Mandelblatt, Howard Andrews +3 more
Logistic regression analyses demonstrated that, in New York City, older Black, lower class women in public hospitals were 3.75 and 2.54 times more likely to have late stage breast or cervical cancer, respectively, than were younger White, high social classWomen in non-public hospitals.
JAMARacial Differences in Survival From Breast Cancer
217 Citations1995Sue A. Joslyn
This investigation is one of the most complete, well-designed, and well-conducted studies to determine the nature of racial differences in breast cancer survival, and the data-collection methods, management of confounding factors, and statistical analyses were exceptional.
JAMARacial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study
216 Citations1994J. William Eley
JAMALikelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation
165 Citations1996Karla Kerlikowske
Annals of Internal MedicineIdentification of Adverse Events Occurring during Hospitalization
163 Citations1990Troyen A. Brennan, A. Russell Localio +5 more
The majority of adverse events and episodes of negligent care are discoverable with the methods used to evaluate medical records, and the adverse events the authors failed to discover led to less costly malpractice claims.
RadiologyBreast cancer: age-specific growth rates and screening strategies.
155 Citations1986Myron Moskowitz
The results of the present study and those of recent Dutch and Swedish trials suggest that the most effective screening strategy may be annual mammographic and clinical examinations for women aged 40-49 years and biennial examinations thereafter.
CancerRacial differences in timeliness of follow-up after abnormal screening mammography
127 Citations1996Sophia W. Chang, Karla Kerlikowske +4 more
A retrospective record review of diagnostic tests for women with abnormal screening mammography from a Northern California mobile van program was conducted to determine whether patient race was associated with timeliness of follow‐up after abnormal screening Mammography.
CancerA collaborative study of differences in the survival rates of black patients and white patients with cancer
112 Citations1992Jan Howard, Benjamin F. Hankey +5 more
The design, methodology, underlying hypotheses, and patient accrual of this study are discussed, and analyses focus on seven main explanatory hypotheses.
JAMALikelihood Ratios for Modern Screening Mammography
109 Citations1996Karla Kerlikowske
The LRs for screening mammography interpreted as "suspicious for malignancy" are high and are associated with a substantial increase in the risk of breast cancer irrespective of age, but these interpretations comprise only a small proportion of abnormal mammography.
CA A Cancer Journal for CliniciansEvaluation of common breast problems: guidance for primary care providers
57 Citations1998Blake Cady, G. Daxton Steele +6 more
CancerMedical and legal implications of screening and follow-up procedures for breast cancer
44 Citations1990John S. Spratt, Shelley W. Spratt
This article will review problems, placing specific emphases on screening and follow‐up procedures and on strategies for breast cancer, and factors that limit efficacy and increase both cost and diagnosis‐associated morbidity will be explored.
American Journal of Clinical OncologyBreast Cancer–Biology and Malpractice
20 Citations1991David Plotkin, Francis G. Blankenberg
Modest evidence for cure of breast cancer is largely based on the results of the Health Insurance Plan study, but important methodologic problems of the study warrant cautions interpretation.
Surgical Oncology Clinics of North AmericaLawsuits for Failure to Diagnose Breast Cancer: Tumor Biology in Causation and Risk Management Strategies
20 Citations1994Deborah B. Diercks, Blake Cady
The idea that plaintiff patients alleging failure to diagnose breast cancer might represent a unique disease state was suggested to the senior author in defense expert witness testimony, malpractice case reviews, and clinical practice.
PubMedPractice guidelines & medical malpractice litigation.
6 Citations1997King Jy
How the parameters are established, their effect on the strategies of litigation, the resultant trial problems in the introduction of evidence and in the burden of proof and their potential for acceptance by a significant number of jurisdictions-are the issues to be explored in this paper.
Postgraduate MedicineLegal issues in managing breast disease
5 Citations1992Marvin A. Dewar, Neil Love
Techniques that help physicians reduce the liability risks associated with breast cancer care include patient education, adequate documentation and follow-up, and referral or consultation in high-risk situations.